drugset / Trial / NCT02341495
Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out if by giving a combination of 3 drugs the leukemia will go into complete remission (meaning the leukemia is completely gone), and to find out how long it stays away. The drugs used in this project are FDA approved and commercially available.
Timeline
- Start
- 2013-02
- Primary completion
- 2016-11
- Completion
- 2016-11
Outcome
Outcome not reported
Stopped (Enrollment): “Study was terminated early due to low patient accrual.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azacitidine | Other / unclassified | 75 mg/m2 | Subcutaneous |
| Subject | Cholecalciferol | Other / unclassified | 4000 iu | Oral |
| Subject | Deferasirox | Unknown | 20 mg/kg | Oral |